Answers are grounded in this paper and cite their sources.
Low-molecular-weight dextran is utilized by many microsurgeons after free tissue transfer for its beneficial effects on the microcirculation. While it is generally felt to have a low rate of complications, severe complications secondary to dextran's osmotic effects may occur. We report here on two cases in which therapy with low-molecular-weight dextran was strongly implicated as a causative factor in major complications. These cases and their background are reviewed. Guidelines for the safe administration of this agent in patients post free-tissue transfer are discussed.
No takes yet. Share an insight, caveat, or question.
Hardin et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: